These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2354665)

  • 21. Squamous mucosa overlying columnar epithelium in Barrett's esophagus in the absence of anti-reflux surgery.
    Sampliner RE; Steinbronn K; Garewal HS; Riddell RH
    Am J Gastroenterol; 1988 May; 83(5):510-2. PubMed ID: 3364411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Please, not another marker of cancer risk in Barrett's esophagus!
    Fennerty MB; Sampliner RE
    Am J Gastroenterol; 1995 Mar; 90(3):511-2. PubMed ID: 7872303
    [No Abstract]   [Full Text] [Related]  

  • 23. Predicting presence of intestinal metaplasia and dysplasia in columnar-lined esophagus: a multivariate analysis.
    Kerkhof M; Steyerberg EW; Kusters JG; Kuipers EJ; Siersema PD
    Endoscopy; 2007 Sep; 39(9):772-8. PubMed ID: 17703384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Symptomatic esophageal stricture and buried metaplasia after radiofrequency ablation of Barrett's esophagus.
    Janssens F; Rougemont AL; Deviere J; Fockens P; Dumonceau JM
    Endoscopy; 2009; 41 Suppl 2():E214-5. PubMed ID: 19757360
    [No Abstract]   [Full Text] [Related]  

  • 25. Reflux esophagitis and ectopic columnar epithelium (Barrett's esophagus) in the esophageal stump after cervical gastroplasty.
    da Rocha JR; Cecconello I; Riberio U; Gama-Rodrigues J
    Am J Gastroenterol; 2005 Feb; 100(2):499. PubMed ID: 15667516
    [No Abstract]   [Full Text] [Related]  

  • 26. Enhanced expression of decay-accelerating factor, a complement-regulatory protein, in the specialized intestinal metaplasia of Barrett's esophagus.
    Hiraoka S; Mizuno M; Nasu J; Okazaki H; Makidono C; Okada H; Terada R; Yamamoto K; Fujita T; Shiratori Y
    J Lab Clin Med; 2004 Apr; 143(4):201-6. PubMed ID: 15085078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Editorial: Defining a bad Barrett's segment: is it dependent on goblet cells?
    Vieth M; Barr H
    Am J Gastroenterol; 2009 Apr; 104(4):825-7. PubMed ID: 19343024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus.
    Lord RV; Park JM; Wickramasinghe K; DeMeester SR; Oberg S; Salonga D; Singer J; Peters JH; Danenberg KD; Demeester TR; Danenberg PV
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):246-53. PubMed ID: 12579092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Duplication of the muscularis mucosae in Barrett esophagus: an underrecognized feature and its implication for staging of adenocarcinoma.
    Abraham SC; Krasinskas AM; Correa AM; Hofstetter WL; Ajani JA; Swisher SG; Wu TT
    Am J Surg Pathol; 2007 Nov; 31(11):1719-25. PubMed ID: 18059229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical options and outcomes in Barrett's esophagus.
    Zaninotto G; Rizzetto C
    Curr Opin Gastroenterol; 2007 Jul; 23(4):452-5. PubMed ID: 17545785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Barrett esophagus and dysplasia].
    Pérez Machado L
    G E N; 1989; 43(3):232-4. PubMed ID: 2535566
    [No Abstract]   [Full Text] [Related]  

  • 32. Surveillance and surgery for Barrett's esophagus: more results from Sweden.
    Lord RV; Gurski RR
    Am J Gastroenterol; 2002 Aug; 97(8):2136-7. PubMed ID: 12190192
    [No Abstract]   [Full Text] [Related]  

  • 33. Paris Workshop on Columnar Metaplasia in the Esophagus and the Esophagogastric Junction, Paris, France, December 11-12 2004.
    Endoscopy; 2005 Sep; 37(9):879-920. PubMed ID: 16116544
    [No Abstract]   [Full Text] [Related]  

  • 34. Barrett's oesophagus with predominant intestinal metaplasia correlates with superficial cyclo-oxygenase-2 expression, increased proliferation and reduced apoptosis: changes that are partially reversed by non-steroidal anti-inflammatory drugs usage.
    Amano Y; Ishihara S; Kushiyama Y; Yuki T; Takahashi Y; Chinuki D; Miyake T; Miyaoka Y; Rumi MA; Ishimura N; Adachi K; Kinoshita Y
    Aliment Pharmacol Ther; 2004 Oct; 20(7):793-802. PubMed ID: 15379840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective multivariate analysis of factors predictive of complete regression of Barrett's esophagus.
    Weston AP; Badr AS; Hassanein RS
    Am J Gastroenterol; 1999 Dec; 94(12):3420-6. PubMed ID: 10606297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Does GERD play CELLO?].
    Junge U
    Z Gastroenterol; 1998 Oct; 36(10):XXII. PubMed ID: 9846375
    [No Abstract]   [Full Text] [Related]  

  • 37. Total columnar-lined esophagus: a case for congenital origin?
    Haque AK; Merkel M
    Arch Pathol Lab Med; 1981 Oct; 105(10):546-8. PubMed ID: 6895169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P53 protein and malignant progression in Barrett's metaplasia (Barrett's esophagus).
    Younes M; Ertan A; Lechago J
    Am J Gastroenterol; 2003 May; 98(5):1200-1; author reply 1201. PubMed ID: 12809848
    [No Abstract]   [Full Text] [Related]  

  • 39. Epidemiology and molecular biology of Barrett esophagus.
    Casson AG; Williams L; Guernsey DL
    Semin Thorac Cardiovasc Surg; 2005; 17(4):284-91. PubMed ID: 16428034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between rate of change in acid exposure along the esophagus and length of Barrett's epithelium.
    Tharalson EF; Martinez SD; Garewal HS; Sampliner RE; Cui H; Pulliam G; Fass R
    Am J Gastroenterol; 2002 Apr; 97(4):851-6. PubMed ID: 12003418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.